Estabrook Capital Management Eli Lilly & CO Transaction History

Estabrook Capital Management

$671 Billion
Q3 2024

A detailed history of Estabrook Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Estabrook Capital Management holds 6,094 shares of LLY stock, worth $4.85 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

6,094

Previous 6,694 8.96%

Holding current value

$4.85 Million

Previous $6.06 Billion 10.92%

% of portfolio

0.81%

Previous 0.93%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $463,284 - $576,012	-600 Reduced 8.96%	6,094 $5.4 Billion
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $314,593 - $394,523	-434 Reduced 6.09%	6,694 $6.06 Billion
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $318,603 - $426,246	-538 Reduced 7.02%	7,128 $5.55 Billion
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $246,839 - $290,991	-470 Reduced 5.78%	7,666 $4.47 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $325,590 - $448,875	-749 Reduced 8.43%	8,136 $4.37 Billion
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $282,345 - $377,528	-805 Reduced 8.31%	8,885 $4.17 Billion
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $31,063 - $36,482	100 Added 1.04%	9,690 $3.33 Billion
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $109,327 - $127,387	-340 Reduced 3.42%	9,590 $3.51 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $126,004 - $143,594	-425 Reduced 4.1%	9,930 $3.21 Billion
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $42,088 - $49,417	-151 Reduced 1.44%	10,355 $3.36 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $158,415 - $196,870	-675 Reduced 6.04%	10,506 $3.01 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $440,481 - $546,639	-1,959 Reduced 14.91%	11,181 $3.09 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $79,776 - $98,175	-360 Reduced 2.67%	13,140 $3.04 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $30,693 - $39,701	-170 Reduced 1.24%	13,500 $3.1 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $49,296 - $63,816	-300 Reduced 2.15%	13,670 $2.55 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $23,743 - $31,418	-182 Reduced 1.29%	13,970 $2.36 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $88,170 - $101,985	-603 Reduced 4.09%	14,152 $2.09 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 0.67%	14,755 $2.42 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $5,952 - $7,367	-50 Reduced 0.34%	14,855 $2.06 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $10,692 - $13,243	-100 Reduced 0.67%	14,905 $1.96 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $11,746 - $12,777	110 Added 0.74%	15,005 $1.68 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 0.67%	14,895 $0
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $30,498 - $35,899	-274 Reduced 1.79%	14,995 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $50,726 - $56,828	-479 Reduced 3.04%	15,269 $1.77 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $15,025 - $18,779	-175 Reduced 1.1%	15,748 $0
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $34,065 - $39,096	-450 Reduced 2.75%	15,923 $0
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $22,411 - $26,455	-302 Reduced 1.81%	16,373 $0
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $1.29 Million - $1.43 Million	16,675	16,675 $0

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Estabrook Capital Management with notifications on news.

Account

Estabrook Capital Management Eli Lilly & CO Transaction History